Pfizer
Search results
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
Here at GSK, we unite science, technology and talent to get ahead of disease together. We are committed to doing the right thing: our ambition is to improve the lives of billions across the world. By bringing together outstanding people, doing work that matters in an inclusive environment, so we can make an impact on a global scale.
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.
Visit our global website for latest results. Press releases. July 11 2024 GSK begins shipping influenza vaccine doses for 2024-25 season. June 26 2024 Statement: US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices updates recommendations on adult RSV vaccines ahead of the next season.
Every day, our general medicines improve health and make life better for millions all over the world and our portfolio of more than 150 primary care products supplied in 112 countries worldwide. View our product areas. Our vaccines and medicines. Getting ahead means preventing disease as well as treating it.
Our portfolio spans three product areas: vaccines, specialty and general medicines. Globally, we’re prioritising R&D investment in vaccines and specialty medicines, which we expect to grow to around three quarters of our business by 2026.
As one of the leading Indian biopharma companies, GSK unites science, technology and talent to get ahead of disease together.
By pursuing this purpose together, we have the scale and expertise to positively impact the health of 2.5 billion people by the end of the decade. In doing so, we will deliver stronger and more sustainable growth as a company where people can thrive. Explore our Purpose, strategy and culture.
We deliver over two million vaccine doses per day to people living in over 160 countries. The vaccines in our portfolio have been helping to protect people from serious disease for well over 100 years, with our Marietta, PA site dedicated to smallpox vaccine production since 1882.
Products. Learn more about our product portfolio and how we're prioritizing vaccines and specialty medicines to get ahead of disease together. Below you can find the full A-Z list of our products available in the United States.
